Esperion Therapeutics shares owned by UBS O'Connor
Quarter-by-quarter ownership of Esperion Therapeutics (ESPR) shares owned by UBS O'Connor
from 13F filings
Historical chart of UBS O'Connor investment in Esperion Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Esperion Therapeutics held by UBS O'Connor consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Esperion Therapeutics by UBS O'Connor
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-03-31 | $382k | 142k | 2.68 |
2023-09-30 | $619k | 632k | 0.98 |
2023-06-30 | $413k | 297k | 1.39 |
2023-03-31 | $328k | 206k | 1.59 |
2022-12-31 | $274k | 216k | 1.26 |
2022-09-30 | $516k | 77k | 6.70 |